Foresite Capital Management Iv, LLC Pharvaris N.V. Transaction History
Foresite Capital Management Iv, LLC
- $87.8 Million
- Q1 2025
A detailed history of Foresite Capital Management Iv, LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Foresite Capital Management Iv, LLC holds 4,410,581 shares of PHVS stock, worth $70.5 Million. This represents 78.82% of its overall portfolio holdings.
Number of Shares
4,410,581
Previous 4,397,881
0.29%
Holding current value
$70.5 Million
Previous $84.3 Million
17.86%
% of portfolio
78.82%
Previous 77.49%
Shares
7 transactions
Others Institutions Holding PHVS
# of Institutions
50Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$120 Million3.99% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$68.6 Million72.08% of portfolio
-
Viking Global Investors LP3.65MShares$58.4 Million0.19% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$52.8 Million17.41% of portfolio
-
Vr Adviser, LLC New York, NY3.11MShares$49.8 Million11.8% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $540M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...